Prognostic significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib: A retrospective analysis.

Medicine (Baltimore) · 2022 · PMC8812594 · PMID 35119010

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significanceP = .05actually significant

Multivariate analysis confirmed that sarcopenia was an independent negative prognostic factor for OS (HR, 0.257, 95% CI, 0.083–0.794; P = .02) in HCC patients treated with lenvatinib, and was associated with worse PFS although the association did not reach statistical significance (HR, 0.431, 95% CI, 0.185–1.003; P = .05).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.